Navigation Links
Experts examine problems and advances in blood supply safety and screening
Date:3/21/2011

Some 14 million units of blood are transfused in the US every year. Routine blood screening protocols test for several common pathogens, including Hepatitis B and C, HIV types 1 and 2, and syphilis, but not others such as XMRV, a retrovirus that has been linked to chronic fatigue syndrome. A symposium at the New York Academy of Sciences on March 29 will reveal recent advances in the testing and screening of the blood supply, diagnose the current problems, and explore future efforts to maximize the safety of this vital resource.

WHAT: A Scientific Symposium: Pathogens in the Blood Supply

WHO:
Organizers
Lorrence H. Green, PhD, Westbury Diagnostics
Jennifer S. Henry, PhD, The New York Academy of Sciences

Speakers
Gail Moskowitz, MD, Healthcare Consultant
Susan L. Stramer, PhD, American Red Cross
W. Ian Lipkin, MD, Mailman School of Public Health, Columbia University
Judy A. Mikovits, PhD, Whittemore Peterson Institute for Neuro-Immune Disease
Debra Kessler, RN, MS, New York Blood Center
Sanjai Kumar, PhD, FDA

WHEN: Tuesday, March 29, 2011 | 1:00 pm 5:00 pm
Networking Reception to Follow

WHERE: The New York Academy of Sciences
7 World Trade Center, 250 Greenwich St., 40th floor, New York, NY

This symposium is presented by Academy's Emerging Infectious Diseases & Microbiology Discussion Group and the Translational Medicine Initiative with support from the Josiah Macy Jr Foundation and the Mushett Family Foundation, and sponsorship from the New York Blood Center and Cerus Corporation.


'/>"/>

Contact: Carmen McCaffery
cmccaffery@nyas.org
212-298-8642
New York Academy of Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Experts discuss climate change during UH lecture series
2. Experts to discuss global water crisis
3. More research needed to make good on biofuel promise, experts say
4. Experts agree: Environmental standards needed for biofuels
5. Kount Lands Veteran Fraud Experts From Retail Decisions and iovation
6. Experts agree: to protect the environment, biofuel standards are needed
7. Recommendations for childrens exercise lacking say experts
8. Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
9. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
10. NAS announces initiative to connect entertainment industry with top experts
11. Experts discuss applying systematic review to the field of nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud with ... Reading ... Used combined in one project, multi-biometric solutions provide a crucial ... Used combined in ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... 2017  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member. David Cox ... North America ), will serve as his ... "We,re pleased to have Ipsen and Dr. Cox join ... . "We welcome their insights in helping us identify ...
(Date:3/28/2017)... ... March 28, 2017 , ... LabKey and ... LabKey’s newest software solution, LabKey Biologics . Built in collaboration with Just ... organizations, LabKey Biologics provides drug research teams tools for biological entity registration, assay ...
(Date:3/28/2017)... Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the ... from its phase 1/2 tendon repair study investigating the use ... a treatment for Achilles tendinosis. ... The clinical trial met its ... and showed no serious adverse events related to the study ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... to accelerating the fight against cancer, autoimmune disease and more through a single-cell ... single-cell metabolomics and proteomics analysis platform developed in the laboratory of Dr. ...
Breaking Biology Technology: